Montelukast sodium in preventing oxygen requirements at day 28 in preterm infants: A multicenter randomized controlled trial

Background Evaluating the efficacy and safety of oral montelukast in preventing oxygen requirement at day 28 of birth in preterm infants admitted to the neonatal intensive care unit through a randomized trial with open-label treatment administration and blinded outcome assessment. Methods Target Population: 92 preterm infants admitted to the Neonatal Intensive Care Units of four hospitals. Intervention: Daily oral administration of 1 mg/kg montelukast. Primary Outcome: Incidence of Oxygen requirement on days 14 and 28 of life. Results Reduction in Oxygen requirement: Significantly lower in the intervention group (31.7%) compared to the control group (55%). Lung Disease Severity: Pulmonary Severity Score was significantly lower in the montelukast group on days 14 and 28. Safety Profile: No serious drug-related adverse effects were reported. Secondary Outcomes: No statistically significant differences were observed regarding mortality or length of hospital stay between the two groups. Conclusion Preventive administration of montelukast in high-risk preterm infants appears to be safe and effective in reducing the incidence of oxygen requirement at day 28/discharge.

Authors

Institutions

Publication Details

Journal
Journal of Neonatal-Perinatal Medicine
Published
2026-11-21
DOI
https://doi.org/10.1177/19345798261509586
Primary Topic
Neonatal Respiratory Health Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Montelukast sodium in preventing oxygen requirements at day 28 in preterm infants: A multicenter randomized controlled trial

Zahra Vahedi, Maryam Saboute, Mandana Kashaki, Arash Mohazzab et al.
Journal of Neonatal-Perinatal Medicine
Neonatal Respiratory Health Research
article

Montelukast sodium in preventing oxygen requirements at day 28 in preterm infants: A multicenter randomized controlled trial

Zahra Vahedi, Maryam Saboute, Mandana Kashaki, Arash Mohazzab, Zahra Soltani, Farhad Abolhasan Choobdar, Majid Karoobi, Farhad Mansoori
article en

Abstract

Background Evaluating the efficacy and safety of oral montelukast in preventing oxygen requirement at day 28 of birth in preterm infants admitted to the neonatal intensive care unit through a randomized trial with open-label treatment administration and blinded outcome assessment. Methods Target Population: 92 preterm infants admitted to the Neonatal Intensive Care Units of four hospitals. Intervention: Daily oral administration of 1 mg/kg montelukast. Primary Outcome: Incidence of Oxygen requirement on days 14 and 28 of life. Results Reduction in Oxygen requirement: Significantly lower in the intervention group (31.7%) compared to the control group (55%). Lung Disease Severity: Pulmonary Severity Score was significantly lower in the montelukast group on days 14 and 28. Safety Profile: No serious drug-related adverse effects were reported. Secondary Outcomes: No statistically significant differences were observed regarding mortality or length of hospital stay between the two groups. Conclusion Preventive administration of montelukast in high-risk preterm infants appears to be safe and effective in reducing the incidence of oxygen requirement at day 28/discharge.

Journal of Neonatal-Perinatal Medicine
Iran University of Medical Sciences (IR), University of Manchester (GB), Shahid Beheshti University of Medical Sciences (IR)
Neonatal Respiratory Health Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Montelukast sodium in preventing oxygen requirements at day 28 in preterm infants: A multicenter randomized controlled trial — Zahra Vahedi, Maryam Saboute, et al. · Journal of Neonatal-Perinatal Medicine (2026) | TGRS Research Map | TGRS